- Home
- SDGR vs HTO Comparison
SDGR vs HTO Comparison
Compare SDGR & HTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDGR
- HTO
- Stock Information
- Founded
- SDGR 1990
- HTO 1985
- Country
- SDGR United States
- HTO United States
- Employees
- SDGR N/A
- HTO N/A
- Industry
- SDGR Biotechnology: Pharmaceutical Preparations
- HTO Water Supply
- Sector
- SDGR Health Care
- HTO Utilities
- Exchange
- SDGR Nasdaq
- HTO Nasdaq
- Market Cap
- SDGR 1.7B
- HTO 1.8B
- IPO Year
- SDGR 2020
- HTO N/A
- Fundamental
- Price
- SDGR $20.46
- HTO $52.28
- Analyst Decision
- SDGR Buy
- HTO
- Analyst Count
- SDGR 5
- HTO 0
- Target Price
- SDGR $32.80
- HTO N/A
- AVG Volume (30 Days)
- SDGR 1.2M
- HTO 228.9K
- Earning Date
- SDGR 07-30-2025
- HTO 07-23-2025
- Dividend Yield
- SDGR N/A
- HTO 0.80%
- EPS Growth
- SDGR N/A
- HTO 12.16
- EPS
- SDGR N/A
- HTO 2.98
- Revenue
- SDGR $230,492,000.00
- HTO $766,656,000.00
- Revenue This Year
- SDGR $24.44
- HTO $6.61
- Revenue Next Year
- SDGR $22.17
- HTO $5.24
- P/E Ratio
- SDGR N/A
- HTO $17.69
- Revenue Growth
- SDGR 22.29
- HTO 12.34
- 52 Week Low
- SDGR $16.60
- HTO $44.91
- 52 Week High
- SDGR $28.47
- HTO $62.18
- Technical
- Relative Strength Index (RSI)
- SDGR 37.57
- HTO N/A
- Support Level
- SDGR $20.90
- HTO N/A
- Resistance Level
- SDGR $21.62
- HTO N/A
- Average True Range (ATR)
- SDGR 1.37
- HTO 0.00
- MACD
- SDGR -0.35
- HTO 0.00
- Stochastic Oscillator
- SDGR 4.46
- HTO 0.00
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.